Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer |
| |
Affiliation: | 1. Department of Pharmacology, School of Pharmacy, Qingdao University Medical College, 1 Ningde Road, Qingdao 266073, China;2. Department of Outpatient and Emergency, the Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266000, China;3. School of Basic Medicine and Institute of Stem Cell and Regenerative Medicine, Qingdao University Medical College, 1 Ningde Road, Qingdao 266073, China;4. Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266000, China;5. Department of Clinical Laboratory, Qingdao Third People''s Hospital, 29 Yongping Road, Qingdao 266041, China;6. Institute of Innovative Drugs, Qingdao University, 38 Dengzhou Road, Qingdao 266021, China. |
| |
Abstract: | The Ca2+-activated Cl? channel ANO1 is widely expressed in epithelial cells, and ANO1 upregulation is implicated in the oncogenesis of many epithelium-originated cancers. However, whether ANO1 plays a causal role in the tumorigenesis of colorectal cancer remains largely unknown. Here, we show that ANO1 channel protein is upregulated in human colorectal cancer tissue samples and its upregulation is correlated with the TNM staging, histological type, pathological differentiation and poor prognosis. Knockdown or pharmacological inhibition of ANO1 suppresses colorectal cancer cell proliferation and induces cell apoptosis. Furthermore, ANO1 knockdown inhibits the growth of subcutaneous xenograft tumors implanted with colorectal cancer HT-29 cells in nude mice. Mechanically, knockdown of endogenous ANO1 inactivates the Wnt/β-catenin signaling through downregulating critical components, such as Frizzled protein 1, β-catenin and upregulating GSK3β. Taken together, our results demonstrate that ANO1 upregulation is involved in the tumorigenesis of colorectal cancer, and inhibition of ANO1 upregulation or inactivating downstream Wnt/β-catenin signaling may have therapeutic potential for colorectal cancer. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|